Terumo Heart Inc. today announced reaching a critical milestone in the worldwide expansion of its DuraHeart™ Left-Ventricular Assist System (LVAS) as the 100th patient was treated with the device.
heart
Results of Medtronic-Supported implantable cardioverter-defibrillator (ICD) Clinical Trial
MVP® (Managed Ventricular Pacing), exclusive programming on Medtronic pacemakers was applied in the MVP Trial of implantable cardioverter-defibrillator patients.
Use Of The MitraClip® Therapy Continues To Expand In Europe, First 100 Patients Treated
Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip® system in Europe.
Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World
The first results from the Medtronic Inc. OMNI Study were released at Heart Rhythm 2009, revealing that one out of six patients received potentially life-saving medical therapy within the two years following their implant.
Medtronic Announces U.S. Trial Of Unique Therapy For Closure Of The Left Atrial Appendage
Medtronic, Inc. announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device as part of a U.S. clinical trial.
St. Jude Medical Announces European Approval of Its Newest and Most Efficient Heart Failure Devices
St. Jude Medical, Inc. today announced European CE Mark approval of its Promote Accel™ implantable cardiac resynchronization therapy defibrillator (CRT-D).
St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices
St. Jude Medical, Inc. today announced U.S. Food and Drug Administration approval of the Promote® Plus cardiac resynchronization therapy defibrillator and Current® Plus implantable cardioverter defibrillators.
Edwards Lifesciences Receives FDA Approval for New Heart Valve
Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced that it has received approval from the U.S. Food and Drug Administration for the Carpentier-Edwards PERIMOUNT Magna Ease aortic valve, designed for easier implantation in the heart.
St. Jude Medical Announces FDA Clearance and Launch of the Attune Annuloplasty Ring for Heart Valve Repair
St. Jude Medical, Inc. today announced the U.S. launch of its Attune™ Flexible Adjustable Annuloplasty Ring for the repair of diseased heart valves.
SCAI Highlights Cardiac Dimensions Inc AMADEUS Study as an Important “Late Breaking” Clinical Trial
The Society of Cardiovascular Angiography and Interventions will highlight Cardiac Dimensions®, Inc.’s AMADEUS™ study during its 32nd annual scientific sessions held in Las Vegas, NV later this week.
Berlin Heart Receives First Regulatory Approval In North America
Berlin Heart GmbH announced it has received its first marketing approval in North America, for the EXCOR® Pediatric ventricular assist device.
Gore Receives FDA Approval For Larger Diameter, Small Profile AAA Endoprosthesis
W. L. Gore & Associates announced that it has received approval from the US Food and Drug Administration to market a 31 mm diameter version of the GORE EXCLUDER® AAA Endoprosthesis.
Trial Shows Important Clinical Benefit Of MitraClip® Therapy In High Risk Patients
Percutaneous mitral valve repair using the MitraClip® system in high-risk surgical patients with improves patient clinical status according to data from the registry arm of the EVEREST II study.
Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.
St. Jude Medical and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
St. Jude Medical, Inc. and GE Healthcare today announced the worldwide commercial launch of the first fully integrated wireless solution for the measurement of Fractional Flow Reserve (FFR).
CardiacAssist Introduces Longer Cannula Set for Its TandemHeart® System
CardiacAssist Inc. announced today that it has introduced a longer cannula set to cardiologists and cardiac surgeons to be used with its TandemHeart® cardiac-assist device: TandemHeart Transseptal Cannula Set—Enhanced Flow 72 (THTC-EF 72).